No intervention is needed for an asymptomatic woman with a minimally elevated testosterone level on hormone replacement therapy.
In an asymptomatic woman on HRT with testosterone one point above the reference range, observation without treatment modification is appropriate. The clinical context and symptom burden—not the laboratory value alone—should guide management decisions.
Key Management Principles
Why No Action Is Warranted
The available guidelines consistently emphasize that testosterone levels in women should not be used to diagnose androgen excess in isolation, particularly in asymptomatic patients 1, 2. The 2008 Endocrine Society guidelines explicitly state that testing for elevated androgens is suggested against in women with isolated findings and no clinical manifestations 1.
Several critical points support observation:
Laboratory variability is substantial: Many commercial laboratories provide inaccurate normal ranges for female testosterone, with the same value potentially classified as normal to abnormally high depending on the reference range used 2. A one-point elevation likely falls within assay variability.
Symptoms drive clinical significance: The Endocrine Society guidelines recommend testing for hyperandrogenemia only when moderate-to-severe hirsutism, rapid progression, virilization, menstrual irregularity, or other concerning features are present 1. Your patient has none of these.
Physiologic testosterone therapy targets are intentionally broad: The 2019 Global Consensus Statement on testosterone therapy in women emphasizes maintaining concentrations "in the physiologic premenopausal range" without defining rigid upper limits, acknowledging individual variation 3.
What to Monitor
Rather than intervening, establish a monitoring framework:
Clinical assessment every 6 months 3:
- Screen specifically for signs of androgen excess: new or worsening hirsutism (facial/body hair), acne, seborrhea, male-pattern balding, voice deepening, clitoromegaly
- Assess for menstrual changes if premenopausal
- Evaluate for mood changes, irritability, or aggressive behavior
Laboratory monitoring:
- Repeat testosterone level in 3-6 months to confirm stability 3
- If levels continue rising or symptoms emerge, obtain comprehensive androgen panel including free testosterone, DHEAS, and 17-hydroxyprogesterone in a reliable specialty laboratory (not a commercial lab) 1, 2
When Further Workup Is Indicated
Pursue additional evaluation only if:
- Testosterone continues to rise on repeat testing
- Clinical signs of hyperandrogenism develop (hirsutism, acne, virilization)
- Rapid onset or progression of any androgenic features 1
- Menstrual irregularities emerge (if premenopausal)
- Abdominal/pelvic mass is detected
If any of these occur, the differential expands to include PCOS, adrenal hyperandrogenism, congenital adrenal hyperplasia, or rarely androgen-secreting tumors, warranting pelvic ultrasound, DHEAS, early morning 17-hydroxyprogesterone, and potentially imaging 1.
Common Pitfalls to Avoid
Do not adjust HRT based on a single mildly elevated value in an asymptomatic patient. This risks undertreating legitimate symptoms the HRT was prescribed to address.
Do not order extensive workups (imaging, dynamic testing) for isolated biochemical findings without clinical correlation 1.
Do not use standard commercial lab assays if repeat testing is needed—these lack accuracy at female testosterone concentrations 2. Specify a specialty endocrine laboratory.
Do not assume the HRT is causative without reviewing the formulation and dosing. If she's on estrogen-only HRT, exogenous testosterone isn't the source. If on testosterone therapy, verify dosing is appropriate (transdermal preferred over oral due to hepatic effects) 3, 4.
Documentation
Document clearly that the patient is asymptomatic with no clinical signs of androgen excess, the elevation is minimal and likely within laboratory variability, and that observation with interval reassessment is the evidence-based approach. This protects against future concerns about "untreated" lab abnormalities while avoiding unnecessary intervention.